«Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway» (2025) Nigerian Journal of Physiological Sciences, 40(2), s. 251–262. doi:10.54548/.